SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 33.34-2.1%Nov 7 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: nigel bates11/6/2006 4:37:31 AM
   of 17367
 
XOMA Receives European Certification to Manufacture Investigational Medicinal Products
Monday November 6, 3:10 am ET

BERKELEY, Calif., Nov. 6, 2006 (PRIMEZONE) -- XOMA Ltd. (NASDAQ:XOMA - News) today announced that its cGMP pharmaceutical manufacturing facilities have received Investigational Medicinal Products certification from the Medicines and Healthcare Products Regulatory Agency (MHRA) of the United Kingdom. The MHRA certification approves XOMA's manufacturing facilities for the production of biological investigational medicinal products to be used in clinical trials in the European Union.

``This is an important development for XOMA since we have a number of our own and partnered drugs in development that are candidates for clinical trials in Europe,'' said Rob Tenerowicz, XOMA's vice president of operations. ``In addition, the MHRA certification positions XOMA to manufacture European investigational drugs on a contract basis for other organizations, which is part of XOMA's strategy for maximizing the utilization of our assets and driving the company to profitability.''...
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext